Microglia and Innate Immunity

Microglia are the resident innate immune cells of the central nervous system. Derived from early myeloid precursors, they populate the brain and spinal cord and serve as the parenchyma's primary sensors of injury, infection, and disturbances in homeostasis. Through constant surveillance and rapid, targeted responses, they integrate immune function with the maintenance and remodeling of neural tissue.

Definition

Microglia are the resident mononuclear phagocytes of the central nervous system that perform innate immune surveillance, respond to molecular signals of damage or infection, and contribute to tissue homeostasis and neural remodeling.

Scope

This topic covers the origin and identity of microglia, their surveillance behaviour, the molecular signals that trigger their activation, and their dual role as protective effectors and potential drivers of injury. It treats microglia as a cellular topic in neuroscience and neuroimmunology, not as a clinical target.

Core questions

• How do microglia survey the healthy brain and detect perturbations?
• What molecular signals shift microglia from surveillance to active responses?
• How do microglial responses become protective versus harmful?
• How does microglial origin and identity differ from peripheral macrophages?

Key concepts

• Resident innate immune cells of the CNS
• Microglial surveillance
• ATP- and purinergic-mediated chemotaxis
• Pattern-recognition receptors
• Microglial activation states
• Phagocytosis and debris clearance
• Yolk-sac myeloid origin

Mechanisms

In the resting state microglia are not quiescent: their fine processes extend and retract continuously, sampling the surrounding parenchyma. Local injury releases nucleotides such as ATP that, acting through purinergic receptors, draw microglial processes rapidly toward the site. Pattern-recognition and other surface receptors allow microglia to detect pathogen- and damage-associated molecules, triggering phagocytosis, cytokine release, and changes in transcriptional state. These responses can clear debris and pathogens and support repair, but sustained or dysregulated activation can release mediators that contribute to neuronal injury.

Clinical relevance

Microglial dysfunction and chronic activation are implicated in neurodegenerative and neuroinflammatory conditions, and microglia are a major focus of research into disease mechanisms and candidate therapies. This entry describes biology and how evidence is generated; it is educational and not a basis for individual diagnosis or treatment.

History

Microglia were first described and named by Pio del Rio-Hortega in the early twentieth century, who recognized them as a distinct glial population. Their function remained obscure for decades until in vivo two-photon imaging in 2005 revealed that resting microglia are highly motile surveillants and respond within minutes to local injury through purinergic signaling. Subsequent lineage-tracing studies established their distinct myeloid origin, and they are now central to neuroimmunology.

Debates

Are simple 'M1/M2' activation categories adequate?

Microglial responses were once described with binary pro- and anti-inflammatory labels borrowed from macrophage biology, but transcriptomic work shows context-dependent states that do not map cleanly onto two categories, and the field has moved toward more nuanced descriptions.

Key figures

• Axel Nimmerjahn
• Wen-Biao Gan
• Marco Colonna
• Oleg Butovsky

Seminal works

• nimmerjahn-2005
• davalos-2005
• colonna-2017

Frequently asked questions

Are microglia the same as other immune cells in the body?

Microglia are tissue macrophages specialized for the central nervous system, but they have a distinct developmental origin from yolk-sac precursors and a transcriptional identity that differs from peripheral macrophages and monocytes.

Are 'resting' microglia inactive?

No. In vivo imaging shows that surveillant microglia constantly extend and retract their processes to monitor the surrounding tissue, so the resting label refers to the absence of overt activation, not to inactivity.